CStone Pharmaceuticals Investor Relations Material
Latest events
H1 2023
CStone Pharmaceuticals
H2 2024
27 Mar, 2025
Investor Update
9 Dec, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from CStone Pharmaceuticals
Access all reports
CStone Pharmaceuticals is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative cancer and autoimmune disease treatments. The company specializes in precision medicine and immuno-oncology therapies, leveraging a pipeline of monoclonal antibodies and targeted small molecules. CStone conducts clinical research and collaborates with global pharmaceutical partners to advance its drug candidates. The company is headquartered in Suzhou, China, and its shares are listed on the HKEX.
Key slides for CStone Pharmaceuticals
Investor Update
CStone Pharmaceuticals
H2 2024
CStone Pharmaceuticals
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
2616
Country
🇭🇰 Hong Kong